Pulmonary clearance of aerosolized 99mTc-DTPA in sarcoidosis I patients

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 51, Issue 1, 2007, Pages 82-90

  Watanabe, N ^a,b   Tanada, S ^a   Sasaki, Y ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^b INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

Author keywords

99mTc DTPA; Aerosol; Pulmonary clearance scintigraphy; Sarcoidosis

Indexed keywords

PENTETATE TECHNETIUM TC 99M; PREDNISOLONE; STEROID;

ADULT; AEROSOL; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DATA ANALYSIS; DRUG HALF LIFE; EYE DISEASE; FEMALE; FOLLOW UP; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG CLEARANCE; LUNG SARCOIDOSIS; MALE; SMOKING; STATISTICAL ANALYSIS; STEROID THERAPY; THORAX RADIOGRAPHY; TRANSBRONCHIAL BIOPSY; TREATMENT DURATION;

ADMINISTRATION, INHALATION; ADULT; AEROSOLS; FEMALE; HUMANS; LUNG; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SARCOIDOSIS, PULMONARY; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M PENTETATE;

EID: 34249681942     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Statement on sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS board of directors and by the ERS executive committee. Am J Respir Crit Care Med 1999;160:736-55.
2. Patrick H. Sarcoidosis. In: Berrs MH, Berkow R, editors. The Merck manual of diagnosis and therapy, 17 ed. New Jersey: Merck & Co., Inc; 1999.p.2482-5.
3. 99m diethylene triamine penta-acetic acid aerosol clearance as an index of lung injury. Eur J Nucl Med 1997;24:81-7.
4. 99mTc-DTPA clearance measured by a dual head gamma camera in healthy subjects and patients with sarcoidosis: studies of reproducibility and relation to bronchoalveolar lavage findings. Eur J Nucl Med 1989;15:71-7.
5. Rinderknecht J, Shapiro L, Krauthammer M, Taplin G, Wasserman K, Uszler JM et al. Accelerated clearance of small solutes from the lungs in interstitial lung disease. Am Rev Respir Dis 1980;121:105-17.
6. Labrune S, Chinet TH, Collignon MA, Barritaut L, Huchon GJ. Mechanisms of increased epithelial lung clearance of DTPA in diffuse fibrosing alveolitis. Eur Respir J 1994;7:651-6.
7. 99m-DTPA clearance rate. J Nucl Med 1994; 35:1993-6.
8. Jacobs MP, Baughman RP, Hughes J, Fernandez-Ulloa M. Radioaerosol lung clearance in patients with active pulmonary sarcoidosis. Am Rev Respir Dis 1985;131:687-9.
9. 99mTc-DTPA and pulmonary involvement in sarcoidosis. Am Rev Respir Dis 1986;134:493-7.
10. 99mTc-DTPA in patients with a subset of stage I sarcoidosis. Nucl Med Commun 1995;16:464-7.
11. Baughman RP, Fernandez M. Radionuclide imaging in interstitial lung disease. Curr Opin Pulm Med 1996;2:376-9.
12. Takahashi T, Azuma A, Abe S, Kawanami O, Ohara K, Kudoh S. Significance of lymphocytosis in bronchoalveolar lavage in suspected ocular sarcoidosis. Eur Respir J 2001;18:515-21.
13. 99mTc-DTPA. Am Rev Respir Dis 1990;141:445-9.
14. Sugisaki K, Yamaguchi T, Nagai S, Ohmiti M, Takenaka S, Morimoto S et al. Clinical characteristics of 195 Japanese sarcoidosis patients treated with oral corticosteroids. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:222-6.
15. Sulavik SB, Spencer RP, Palestro CJ, Swyer AJ, Teirstein AS, Goldsmith SJ. Specificity and sensitivity of distinctive chest radiographic and/or 67Ga images in the noninvasive diagnosis of sarcoidosis. Chest 1993;103:403-9.
16. Lynch DA, Webb WR, Gamsu G, Stulbarg M, Golden J. Computed tomography in pulmonary sarcoidosis. J Comput Assist Tomogr 1989;12:405-10.
17. Lebtahi R, Crestani B, Belmatoug N, Danou D, Genin R, Dombret MC et al. Somatostatin receptor scintigraphy and gallium scintigraphy in patients with sarcoidosis. J Nucl Med 2001;42:21-6.
18. El-Haddad G, Zhuang H, Gupta N, Alavi A. Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders. Semin Nucl Med 2004;34:313-29.
19. Alavi A, Buchpiguel CA, Loessner A. Is there a role for FDG PET imaging in the management of patients with sarcoidosis? J Nucl Med 1994;35:1650-2.